AVGEMSI J Code: J9184

Drug & Product Overview

HCPCS Descriptor Injection, gemcitabine hydrochloride (avyxa), 200 mg

HCPCS Added Date January 1, 2026

Manufacturer Avyxa Pharma

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Multi-Dose

Dosage Form Injection, Solution

About AVGEMSI

Avgemsi is a medication aligned to the HCPCS J Code: J9184 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Avyxa Pharma.

According to CMS Drug Use Information: Gemcitabine is used to treat certain types of cancer (including biliary tract, breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Package	Manufacturer	HCPCS Units	WAC	AWP
83831-0123-01	999.4 MG / 26.3 ML Avgemsi Intravenous Injection 999.4 MG/26.3ML - 1 VIAL, MULTI-DOSE in 1 CARTON (83831-123-01) / 26.3 mL in 1 VIAL, MULTI-DOSE	Avyxa Pharma, LLC	5	$1,998.75 $399.75 / unit	$2,398.50 $479.70 / unit
83831-0124-01	1998.8 MG / 52.6 ML Avgemsi Intravenous Injection 1998.8 MG/52.6ML - 1 VIAL, MULTI-DOSE in 1 CARTON (83831-124-01) / 52.6 mL in 1 VIAL, MULTI-DOSE	Avyxa Pharma, LLC	10	$3,997.50 $399.75 / unit	$4,797.00 $479.70 / unit

Effective 7/1/26 (WAC & AWP)

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

AVGEMSI Pricing & Reimbursement

J9184 Private Payer Reimbursement

$402.49 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

NDC Package

HCPCS Units

Markup / Markdown

%

Common:

Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.

Estimated Reimbursement

Gemcitabine 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9184	Avyxa Pharma	Gemcitabine	Injection, gemcitabine hydrochloride (avyxa), 200 mg
J9196	Accord	Gemcitabine	Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
J9198	Sun Pharma	Gemcitabine	Injection, gemcitabine hydrochloride, (infugem), 100 mg
J9201	Generic Code (Multiple Manufacturers)	Gemcitabine	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

AVGEMSI Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 31.87%

Avg. Days to File 6.3days

Avg. Days to Pay 31.8days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9184 claims analytics on FocalPoint →

AVGEMSI CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

AVGEMSI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Breast Cancer Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer

Drug Class

Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Frequently Asked Questions

Is there a manufacturer-published Avgemsi billing and coding guide?

Billing and coding information for AVGEMSI can be found through Avyxa Pharma, LLC. Visit Here →

Is there an available Avgemsi patient assistance program?

AVGEMSI patient assistance information can be found through Avyxa Pharma, LLC. Visit Here →

Where can I find Avgemsi prescribing information?

Avgemsi prescribing information can be found at the link below. Visit Here →

Where can I find Avgemsi side effect information?

Our team has not identified a source of side effect information for Avgemsi.

Does billing AVGEMSI require JZ/JW wastage modifiers?

CMS does not include AVGEMSI (J9184) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9184. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.